BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9401525)

  • 1. Oral desmopressin treatment of central diabetes insipidus in children.
    Boulgourdjian EM; Martínez AS; Ropelato MG; Heinrich JJ; Bergadá C
    Acta Paediatr; 1997 Nov; 86(11):1261-2. PubMed ID: 9401525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of central diabetes insipidus using oral DDAVP. Comparison with intranasal treatment].
    Carraro A; Fano M; Porcella E; Bernareggi V; Giusti M
    Minerva Endocrinol; 1991; 16(3):141-5. PubMed ID: 1806811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, pharmacodynamics, long-term efficacy and safety of oral 1-deamino-8-D-arginine vasopressin in adult patients with central diabetes insipidus.
    Lam KS; Wat MS; Choi KL; Ip TP; Pang RW; Kumana CR
    Br J Clin Pharmacol; 1996 Sep; 42(3):379-85. PubMed ID: 8877030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP).
    Fjellestad A; Czernichow P
    Acta Paediatr Scand; 1986 Jul; 75(4):605-10. PubMed ID: 3529809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Water-balance hormones during long-term follow-up of oral dDAVP treatment in diabetes insipidus.
    Fjellestad-Paulsen A; Laborde K; Kindermans C; Czernichow P
    Acta Paediatr; 1993 Sep; 82(9):752-7. PubMed ID: 8241672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central diabetes insipidus in children. Antidiuretic effect and pharmacokinetics of intranasal and peroral 1-deamino-8-D-arginine vasopressin.
    Fjellestad-Paulsen A; Tubiana-Rufi N; Harris A; Czernichow P
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):307-12. PubMed ID: 3618082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?
    Broadbent V; Pritchard J
    Med Pediatr Oncol; 1997 Apr; 28(4):289-93. PubMed ID: 9078326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of desmopressin (DDAVP) in diabetes insipidus: solution vs tablets].
    Rampazzo AL; Boscaro M; Mantero F; Piccitto R
    Minerva Endocrinol; 1992; 17(1):37-41. PubMed ID: 1495453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral desmopressin in central diabetes insipidus.
    Westgren U; Wittström C; Harris AS
    Arch Dis Child; 1986 Mar; 61(3):247-50. PubMed ID: 3963868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term treatment of central diabetes insipidus with oral DDAVP].
    Carraro A; Fano M; Cuttica M; Bernareggi V; Giusti M; Giordano G
    Minerva Endocrinol; 1992; 17(4):189-93. PubMed ID: 1308923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The treatment of patients with diabetes insipidus by a synthetic analogue of vasopressin, DDAVP (author's transl)].
    Tanae A; Shimizu K; Yoshida S
    Nihon Naibunpi Gakkai Zasshi; 1978 May; 54(5):676-91. PubMed ID: 689212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of central diabetes insipidus with oral desmopressin in a premature neonate.
    Atasay B; Berberoğlu M; Günlemez A; Evliyaoğlu O; Adiyaman P; Unal S; Arsan S; Ocal G
    J Pediatr Endocrinol Metab; 2004 Feb; 17(2):227-30. PubMed ID: 15055359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of diabetes insipidus with Minirin. Switch from nasal to oral administration].
    Czernichow P
    Ann Endocrinol (Paris); 1998 Dec; 59(5):407-9. PubMed ID: 9949892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDAVP in the treatment of diabetes insipidus: a clinical study.
    Graham JJ; Wise PH; Harding PE
    Med J Aust; 1977 Jul; 2(4):113-6. PubMed ID: 895639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desmopressin (DDAVP) in diabetes insipidus.
    Drug Ther Bull; 1976 Oct; 14(21):81-2. PubMed ID: 976094
    [No Abstract]   [Full Text] [Related]  

  • 17. Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin.
    Hammer M; Vilhardt H
    J Pharmacol Exp Ther; 1985 Sep; 234(3):754-60. PubMed ID: 4032289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin analog DDAVP in the treatment of diabetes insipidus.
    Lee WP; Lippe BM; La Franchi SH; Kaplan SA
    Am J Dis Child; 1976 Feb; 130(2):166-9. PubMed ID: 766613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-Deamino-8-D-arginine vasopressin and urine cyclic adenosine monophosphate excretion in diabetes insipidus.
    Blackett PR; Seely JR; Altmiller DH; Males JL
    Clin Pharmacol Ther; 1981 Jun; 29(6):793-7. PubMed ID: 6262005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of ADP responsive diabetes insipidus in children with DDAVP (1-desamino-8-D-arginine-vasopressin)].
    Limal JM; Mugner E; Czernichow P
    Arch Fr Pediatr; 1977 Dec; 34(10):965-72. PubMed ID: 610662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.